Alantra Partners has sold MBA Incorporado to AddLife
MBA Incorporado is a leading distributor in Southern Europe of orthopedic, trauma, anesthesia and surgical solutions. MBA is based in Spain and operates also in Portugal and Italy, acting as a key partner for surgeons thanks to its differentiated offering with service, support and training to healthcare professionals.
Alantra Partners decided to divest MBA in order to find a new partner to support its growth. Lincoln ran a targeted process, where market knowledge and global reach were key to closing the transaction with an international strategic buyer. With the acquisition of MBA, AddLife is continuing its expansion in Europe and becomes an even more attractive partner for leading suppliers in niche and value-added products.
Iván Marina, Managing Director and Chief Executive Officer of Lincoln Spain, commented, “It was a pleasure to advise Alantra and MBA throughout this transaction. MBA has a highly differentiated value proposition, and we look forward to following its future success as part of AddLife.”
Alantra is the pioneer and one of the leading private equity firms in the Iberian market. With over 25 years of heritage, Alantra is focused on upper mid-market Iberian companies in different sectors such as food and beverage, industrial, healthcare and technology.
AddLife AB (ALIFB:SS) is a listed Swedish medical technology company active in the European market. AddLife owns and acquires market-leading companies in niche segments with offerings aimed at the healthcare sector, from research to medical care. The AddLife share has been listed since 2016 on Nasdaq Stockholm, Large Cap. The head office is located in Stockholm, Sweden.
Lincoln has been a trusted partner for MBA throughout the process. The team’s dedication and experience in cross-border transactions were instrumental in attracting the right buyer and achieving this great outcome for MBA and its shareholders.
Meet our Senior Team
I take an active role in every stage of the transaction process in order to achieve the goals of my clients.
Managing Director | CEO SpainMadrid
View More Transactions in Healthcare
Lincoln International advised Olive AI on the sale of substantially all of its assets to Waystar and Humata Health
Lincoln International advised Scantox Group, a portfolio company of Impilo, on its acquisition of QPS Austria’s Neuropharmacology Division
Lincoln International advised HealthEdge Investment Partners on the sale of Corridor to WellSky, a portfolio company of Leonard Green and TPG Capital
Lincoln International advised Align Capital Partners on the sale of VetEvolve to Varsity Healthcare Partners
Lincoln International advised Havencrest Capital Management on its majority investment in Tekton Research
Lincoln International advised Your Way Medicare on its sale to Accretive, a portfolio company of GTCR
Lincoln International advised Seventure and minority shareholders on the sale of TargEDys to Biocodex
Lincoln International advised KPS Capital Partners on its sale of LRE Medical to Gyrus Capital
Any information or testimonials contained in this post may not be representative of the experience of other clients and is no guarantee of future performance or success.